Introduction
Diverse analogues of -amino nitrile-derived ureas have been described as inhibitors of the cholesteryl ester transfer protein 1 and diverse enzymes, such as dipeptidyl peptidase IV, 2-4 prolyl oligopeptidases, 5 and cysteine cathepsins, 6, 7 as well as agents for neurological disorders, 8 pesticides, 9 and fungicides. 10 On the other hand, -amino nitrile-derived ureas are intermediates in the synthesis of diverse pharmacologically active hydantoin derivatives from -amino nitriles. [11] [12] [13] In view of these precedents and in the context of a medicinal chemistry project focused on the search of antagonists of the thrombin receptor PAR1, 14, 15 by exploring the use of -amino acid-derived amino nitriles as molecular diversity generators, 16 we have recently described a versatile solvent-free synthesis of basic amino acid-derived N-(cyanomethyl)ureas of general formula A. 17 Now, taking into account that hydantoins (imidazolidine-2,4-diones) are included among privileged scaffolds in medicinal chemistry, 18, 19 natural products [20] [21] [22] [23] [24] [25] [26] and organic synthesis, 19, 27 we have studied and report herein the cyclization of cyanomethylureas A to imidazolidin-2-one derivatives B (Scheme 1).
Scheme 1. Proposed synthesis of imidazolidin-2-one
derivatives B
Results and discussion
In general, the synthesis of hydantoins by cyclization of -amino nitriles involves reaction with isocyanates, followed by in situ acid hydrolysis of the corresponding intermediate N-(cyanomethyl)ureas. 28, 29, 11, 30 As we were interested in preserving the Boc protection at the basic side chain of N-(cyanomethyl)ureas A, the cyclization in acid media was initially excluded and we decided to try it first under neutral or basic reaction conditions. The ornithine derived N-(cyanomethyl)urea (S)-1a (Scheme 2) was chosen for setting up the methodology. The cyclization was initially attempted by heating (S)-1a in refluxing MeOH. As shown in Table 1 (entry 1), after 15 min of reaction, the HPLC-MS analysis of the crude reaction mixture showed the presence of the epimeric mixture of 4-iminoimidazolidin-2-ones (RS)-2a, as minor products (9%), along with oxidation products, 31, 32 the 5-hydroxy-4-iminoimidazolidin-2-ones (RS)-3a (78%) and the 5-benzylidene-4-iminoimidazolidin-2-one 4a (13%). To avoid oxidation, the next experiments were carried out under argon and MeOH was replaced by other solvents. In this way, the starting urea (S)-1a remained unaltered after 2 days in toluene or CH 3 CN at 100 ºC. Then, we tried to add a catalytic amount of base 33 (10 %, Et 3 N, K 2 CO 3 , and Cs 2 CO 3 ), which activated the reaction and decreased the formation of oxidation products. Thus, both Et 3 N in toluene and K 2 CO 3 , or Cs 2 CO 3 in CH 3 CN led to ≈ 40% of (RS)-2a (entries 2-4). The increase of base to 100% and the reaction temperature up to 100 ºC, by MW irradiation, in CH 3 CN allowed to decrease the reaction time and to increase the yield of the 4-iminoimidazolidin-2-ones (RS)-2a up to 88% (entry 5). Finally, the improvement was particularly noteworthy when the reaction was carried out without solvent (entries 6 and 7), which yielded quantitatively the desired products (RS)-2a after 5 min of reaction. 3 and in (CD 3 ) 2 CO showed the presence of two isomers, as well as the disappearance of the ureido NH and the appearance of two signals for the 5-H of the imidazolidin-2-one ring at ≈ 0.45 ppm higher field than the proton in position  to the CN group of (S)-1a. The imine NH proton could not be observed, probably due to its fast exchange. No significant changes were observed in the signals corresponding to the benzylamide group, with respect to those of the starting urea (S)-1a. This fact discarded the alternative cyclization through this group to give an isomeric 6-imino-piperazine-2-one ring. The duplicity of peaks in the HPLC-MS and of signals in the NMR spectra indicated that the cyclization occurred with epimerization at the C 5 due to an equilibrium between the 4-iminoimidazolidin-2-one structure 2a and its tautomer 4-amino-2,3-dihydro-1H-imidazol-2-one 5a (Scheme 3). The racemization of optically active 5-benzylhydantoins has been explained through a similar tautomerism 34 and Bepary et al. have recently reported the tautomerism of 2-iminoimidazolidin-2-ones. 35 Interestingly, the HPLC-MS analysis of the cyclization of (S)-1a in MeOH (Table  1 , entry 1) showed only one peak at 3.67 min. This fact suggested us that the tautomer equilibrium could be controlled by the solvent and that 5a could be the main tautomer in MeOH. Then, we attempted to study this tautomer equilibrium by registering the 1 H NMR spectrum of (RS)-1a in CD 3 OD at different times. After 3 h, the cyclization was complete, but, unfortunately, the overlapping of the CD 3 OD signals with those of the cyclization products avoided their unequivocal assignment. We also tried to trap the tautomers by acetylation. For that purpose, the cyclization of (S)-1a was carried out solvent-free and under Ar, by MW heating at 100 ºC in the presence of 2 equivalents of acetyl chloride and Et 3 N. The HPLC-MS analysis of the crude reaction mixture showed the formation of a unique acetylated derivative, to which we assigned the structure of the 4-acetamido-2,3-dihydro-1H-imidazol-2-one 6a, based on its 1 H NMR spectrum in CDCl 3 . Thus, the 5-H proton of (RS)-2a had disappeared and the 5-CH 2 protons appeared as an AB system [at 3.72 and 3.79 ppm and J = 16.5 Hz, ≈ 0.5 ppm lower field than the corresponding protons in (RS)-2a]. However, the acetylated compound 6a resulted highly unstable and the NMR sample completely decomposed during the 13 C NMR registration time (≈ 8 h). This 13 C NMR spectrum showed a complex mixture that could not be assigned. The decomposition was also evident in the HPLC-MS analysis of the recovered NMR sample, which showed the almost complete disappearance of the peak corresponding to 6a and the appearance of multiple peaks of oxidation products.
Scheme 2. Cyclization of the N-(cyanomethyl)urea (S)-1a as indicated in

Scheme 3. Synthesis, tautomerism and acetylation of the 4-iminoimidazolidin-2-ones (RS)-2a
In view of the epimerization observed in the cyclization of (S)-1a, the versatility of the MW-promoted and base-catalyzed solvent-free cyclization was studied using epimeric mixtures of the N-(cyanomethyl)ureas (RS)-1a-e (Scheme 4). In this way, the corresponding 4-iminoimidazolidin-2-ones (RS)-2a-e were obtained in higher than 95 % yield. Although the HPLC analysis of the crude reactions showed a high degree of purity, the NMR spectra of (RS)-2a-e showed low resolution, due to the presence of mixtures of epimers and to the high tendency of these 4-iminoimidazolidin-2-ones to oxidation. The assignment of these spectra was based on 2D HSQC and HMBC spectra.
Starting urea
Iminoimidazolidin-2-one no.
Ph (RS)-2e 95
Scheme 4. Synthesis of the 4-iminoimidazolidin-2-ones (RS)-2a-e
4-Iminoimidazolidin-2-ones are known to give hydantoins in acid media. 34, 28, 36 Based on this knowledge, we decided to study the hydrolysis of (RS)-2a-e to the corresponding hydantoin derivatives. We first tried the hydrolysis in acid conditions compatible with the presence of the Boc protection in the basic side chain, such as (0.1-1.0 N) HCl in EtOAc, 20% AcOH in MeOH or (1:1:1) AcOH/MeOH/H 2 O at rt. In all cases, the starting 4-iminoimidazolidin-2-ones (RS)-2a were recovered unaltered. Then, we tried the standard acid conditions for Boc removal, 3N HCl in EtOAc and 20% TFA in CH 2 Cl 2 , at rt. After 30 min, the removal of the Boc group was complete in both cases, but the iminoimidazolidin-2-one ring was unaltered. After 24 h, the HPLC-MS of the crude reaction mixture showed 58 % of ring oxidation, but no hydrolysis. Finally, we studied the hydrolysis of (RS)-2a at 100 ºC in concentrated aqueous HCl (12 N). Under these conditions, complete hydrolysis required overnight heating, which, besides the hydrolysis of the iminoimidazolidin-2-one ring, also produced the hydrolysis of the benzyl amide group at the basic amino acid residue to carboxylic acid and partial oxidation of the ring (Scheme 5). The mixture of products (RS)-9a and 10a, although was identified by their [M+1] + in the HPLC-MS analysis, could not be separated.
Scheme 5. Acid hydrolysis of the 4-iminoimidazolidin-2-ones (RS)-2a
In view of the difficulties to obtain hydantoins by hydrolysis of 4-iminoimidazolidin-2-ones, we turned to study their preparation by direct hydrolysis of the starting N-(cyanomethyl)ureas (S)-1a-e. The setting up of reaction conditions was carried out with (S)-1a. As shown in Table 2 , treatment of this urea with 0.1 N solution of HCl in EtOAc for 3 days led almost quantitatively to the Boc-protected 4-iminoimidazolidin-2-ones (RS)-2a (entry 1), while, increasing the HCl concentration up to 3 N gave a mixture of deprotected iminoimidazolidin-2-ones (RS)-7a and the hydantoin (S)-12a (entry 3). As shown in Scheme 6, this compound was the only reaction product when the hydrolysis was carried out in 20 % TFA solution in CH 2 Cl 2 at rt (entry 4) or in 12 N aqueous HCl at 100 ºC (entry 5). In this latter case, neither hydrolysis of the benzyl amide group nor epimerization at C 5 was observed. This different behavior respect to the commented hydrolysis of 4-iminoimidazolidin-2-ones (RS)-2a suggested that the hydrolysis mechanism was different and that it should not go through the 4-iminoimidazolidin-2-ones (RS)-7a. To study the process, the TFA-mediated reaction was monitored by HPLC-MS at different times. which confirmed the mechanism. In view of the good results of this methodology, it was applied to the synthesis of the series (S)-12a-e (Scheme 6). These hydantoins derivatives were isolated from the reaction mixtures as TFA salts in higher than 95 % yield and were screened as antagonists of the thrombin receptor PAR1 in an assay of human platelet aggregation inhibition. 14 None of them displayed significant activity at 0.1 mg/mL concentration. b Isolated yield.
Scheme 6. Synthesis of the hydantoin derivatives (S)-12a-e by acid hydrolysis of the N-(cyanomethyl)ureas (S)-1a-e 3. Conclusions
In conclusion, the results herein described show that N-(cyanomethyl)ureas display a chameleonic reactivity that can act as a double-edged sword. Adequately controlled, this reactivity may have high synthetic potentiality. Thus, under neutral, basic or mild acid media they cyclize to 4-iminoimidazolidin-2-one derivatives, which tautomerize to 4-amino-2,3-dihydro-1H-imidazol-2-ones. This tautomerism triggers epimerization at the C 5 of the imidazolidine ring, as well as its oxidation. However, under strong acid media, N-(cyanomethyl)ureas in a noepimerizing two-step hydrolysis, through the corresponding carboxylic acids, give stable highly functionalized hydantoin derivatives.
Experimental section
General methods
All reagents were of commercial quality. Solvents were dried and purified by standard methods. Analytical TLC was performed on aluminum sheets coated with a 0.2 mm layer of silica gel 60 F 254 . Silica gel 60 (230-400 mesh) was used for flash chromatography. Analytical RP-HPLC was performed on a Sunfire C 18 (4.6×150 mm, 3.5 μm) column, with a flow rate of 1 mL/min, using a tunable UV detector set at 214 and 254 nm and gradient of CH 3 CN (solvent A) and 0.05 % TFA in H 2 O (solvent B) as mobile phase. HPLC-MS was performed on a Sunfire C 18 (4.6×50 mm, 3.5 μm) column at 30°C, with a flow rate of 1 mL/min and gradient of 0.1% of formic acid in CH 3 CN (solvent A) in 0.1% of formic acid in H 2 O (solvent B) was used as mobile phase. Electrospray in positive mode was used for ionization. NMR spectra were recorded using Varian Inova 300, Varian Inova or Mercury 400, and Varian Unity 500 spectrometers. The NMR spectra assignments were based on COSY, HSQC, and HMBC spectra. MW experiments were carried out in sealed vessels in a MW Emrys TM Synthesizer (Biotage AB), with transversal IR sensor for reaction temperature monitoring.
General procedure for the solvent-free synthesis of the 4-iminoimidazolidin-2-ones (RS)-2a-e
Et 3 N (28 L, 0.2 mmol) was added under argon to a solution of the corresponding N-(cyanomethyl)urea (RS)-1a-e (0.2 mmol) in CH 2 Cl 2 (0.50 mL). After 5 min of stirring at room temperature, the solvent was evaporated under argon stream. The homogeneous mixture was heated at 100 ºC by MW irradiation for 5 min. After cooling to rt, the crude reaction was dissolved in EtOAc (10 mL), washed with H 2 O (3×3 mL) and brine (3 ml), dried over Na 2 SO 4 , and concentrated under vacuum. The residue was purified by flash chromatography, using 0-15% MeOH in 5 CH 2 Cl 2 gradient as eluent, to afford the title compounds (RS)-2a-e as foams that decomposed on standing. 5 , 1 2 6 . 5 , 1 2 6 . 8 , 1 2 6 . 9 , 1 2 6 . 9 , 1 2 7 . 1 , 1 2 7 . 4 ,  1 2 7 . 5 , 1 2 7 . 7 , 1 2 7 . 8 , 1 2 7 . 8 , 1 2 7 . 8 , 1 2 7 . 8 , 1 2 7 
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Acid hydrolysis of the N-(cyanomethyl)ureas (S)-1a-e. Synthesis of the hydantoin derivatives (S)-12a-e.
The corresponding N-(cyanomethyl)urea (S)-1a-e [0.125 mmol, impurified with 0-30 % of the respective epimer (R)-1a-e, due to the difficulty of resolution of the epimeric mixtures (RS)-1a-e] was dissolved in 20 % solution of TFA in CH 2 Cl 2 (5 mL). After 24 h of stirring at rt, the reaction mixture was evaporated to dryness. The residue was coevaporated with CH 2 Cl 2 (3×2 mL) and triturated with cold ethyl ether. The residue was dissolved in H 2 O (3 mL) and the solution was lyophilized. In this way, the trifluoroacetates of the hydantoin derivatives (S)-12a-e were obtained as amorphous solids retaining the epimer ratio of the starting urea 1a-e [70-100 % of the (S)-epimer]. 
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